🔎 Trials Near Me

Utama › Limfoma Zon Tepi › Missouri

Kajian klinikal Limfoma Zon Tepi di Missouri

6 kajian untuk Limfoma Zon Tepi sedang mencari peserta di lokasi di Missouri.

Bandar di Missouri

Teks kajian rasmi (Bahasa Inggeris)

Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

  • Saint Francis Medical Center, Cape Girardeau
  • Heartland Regional Medical Center, Saint Joseph
  • Mercy Hospital South, St Louis
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT04840602

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

  • Washington University School of Medicine, St Louis
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Jul 2026 · NCT07121946

64Cu-LLP2A for Imaging Hematologic Malignancies

  • Washington University School of Medicine, St Louis
Mengambil pesertaFasa awal 1Sukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Jun 2026 · NCT06636175

Pirtobrutinib in Combination With Rituximab in Adults With Untreated Marginal Zone Lymphoma (PIONEER-MZL)

  • Washington University, St Louis
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Dis 2025 · NCT06390956

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

  • Washington University, St Louis
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Nov 2025 · NCT05643742

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Kansas City
  • Massive Bio SYNERGY-AI site, St Louis
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.